Start Here - Investing in Life Science
This report is free. No credit card required.
While the life sciences sector is not immune to the vagaries of stock markets and macroenomic trends such as inflation and economic growth, recent numbers show that it has done quite well in the face of some challenging economic headwinds.
The sector is also considered a safe haven due to baby boomers — a large and growing market segment whose consumption of pharmaceuticals and need for an endless array of healthcare services is only going to get more pressing.
Interested in investing? Get our Free report: Start Here – Investing in Life Sciences
Table of Contents
- Pharmaceutical Outlook 2017: Seeking a Competitive Edge
- Investing in Pharmaceutical Companies: What You Need to Know
- Biotech Outlook 2017: After the Storm
- Top Biotech Trends for 2017
- Medical Device Outlook 2017: Radical Innovation Raises Regulatory Questions
- Top Medical Device Trends for 2017
- Genetics Outlook 2017: The Revolution Nears
- An Introduction to TSXV Life Science Stocks
- 4 Top Life Science Stocks on the TSX Venture 50